CorMedix, Inc. (CRMD)
8.055
+0.12
(+1.58%)
USD |
NASDAQ |
May 21, 16:00
8.055
0.00 (0.00%)
After-Hours: 19:59
CorMedix Shareholders Equity (Quarterly) : 437.05M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 90.10B |
| Eli Lilly & Co. | 31.20B |
| Theravance Biopharma, Inc. | 290.59M |
| Hyperion DeFi, Inc. | 58.50M |
| Corcept Therapeutics, Inc. | 637.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 815.64M |
| Total Liabilities (Quarterly) | 378.59M |
| Debt to Equity Ratio | 0.3315 |
| Current Ratio | 2.975 |
| Net Debt Paydown Yield | -5.42% |